Your browser doesn't support javascript.
loading
SORLA regulates endosomal trafficking and oncogenic fitness of HER2.
Pietilä, Mika; Sahgal, Pranshu; Peuhu, Emilia; Jäntti, Niklas Z; Paatero, Ilkka; Närvä, Elisa; Al-Akhrass, Hussein; Lilja, Johanna; Georgiadou, Maria; Andersen, Olav M; Padzik, Artur; Sihto, Harri; Joensuu, Heikki; Blomqvist, Matias; Saarinen, Irena; Boström, Peter J; Taimen, Pekka; Ivaska, Johanna.
Affiliation
  • Pietilä M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland. mika.pietila@utu.fi.
  • Sahgal P; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Peuhu E; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Jäntti NZ; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Paatero I; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Närvä E; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Al-Akhrass H; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Lilja J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Georgiadou M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Andersen OM; Danish Research Institute of Translational Neuroscience Nordic-EMBL Partnership (DANDRITE), Department of Biomedicine, Aarhus University, Ole Worms Allé 3, 8000, Aarhus, Denmark.
  • Padzik A; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland.
  • Sihto H; Laboratory of Molecular Oncology, Translational Cancer Biology Program, University of Helsinki and Comprehensive Cancer Center, Helsinki University Hospital, FI-00290, Helsinki, Finland.
  • Joensuu H; Laboratory of Molecular Oncology, Translational Cancer Biology Program, University of Helsinki and Comprehensive Cancer Center, Helsinki University Hospital, FI-00290, Helsinki, Finland.
  • Blomqvist M; Institute of Biomedicine, University of Turku and Department of Pathology, Turku University Hospital, FI-20520, Turku, Finland.
  • Saarinen I; Institute of Biomedicine, University of Turku and Department of Pathology, Turku University Hospital, FI-20520, Turku, Finland.
  • Boström PJ; Department of Urology, University of Turku and Turku University Hospital, FI-20520, Turku, Finland.
  • Taimen P; Institute of Biomedicine, University of Turku and Department of Pathology, Turku University Hospital, FI-20520, Turku, Finland.
  • Ivaska J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520, Turku, Finland. Johanna.ivaska@utu.fi.
Nat Commun ; 10(1): 2340, 2019 05 28.
Article in En | MEDLINE | ID: mdl-31138794

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Membrane Transport Proteins / Endosomes / Urinary Bladder Neoplasms / Breast Neoplasms / Carcinoma, Transitional Cell / Cell Membrane / Carcinoma, Intraductal, Noninfiltrating / Receptor, ErbB-2 / LDL-Receptor Related Proteins Limits: Animals / Female / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2019 Document type: Article Affiliation country: Finland Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Membrane Transport Proteins / Endosomes / Urinary Bladder Neoplasms / Breast Neoplasms / Carcinoma, Transitional Cell / Cell Membrane / Carcinoma, Intraductal, Noninfiltrating / Receptor, ErbB-2 / LDL-Receptor Related Proteins Limits: Animals / Female / Humans Language: En Journal: Nat Commun Journal subject: BIOLOGIA / CIENCIA Year: 2019 Document type: Article Affiliation country: Finland Country of publication: United kingdom